LTS Lohmann Therapie-Systeme AG

About:

LTS Lohmann Therapie-Systeme AG is the market leader in trans dermal therapeutic systems and oral drug films.

Top Investors: Bill & Melinda Gates Foundation

Description:

LTS is a leading pharmaceutical technology company that develops and manufactures innovative drug delivery systems such as Transdermal Patches ("TTS") and Oral Thin Films ("OTF") for the pharmaceutical industry. While we continuously refine our TTS and OTF technologies further, we also research complementary Micro Array Patches for the transdermal delivery of large molecule, biological actives. Incorporated in 1984, we operate today from two sites in Andernach, Germany and West Caldwell/NJ, USA, plus representative office in Shanghai/China.

Total Funding Amount:

$5.5M

Estimated Revenue Range:

$100M to $500M

Headquarters Location:

Andernach, Rheinland-Pfalz, Germany

Founded Date:

1984-01-01

Founders:

Number of Employees:

1001-5000

Last Funding Date:

2023-12-19

IPO Status:

Private

Industries: